Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia

Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia

One of the key features of acute myeloid leukemia (AML), a group of very aggressive myeloid malignancies, is their strikingly heterogenous outcomes. Accurate biomarkers are needed to improve prognostic assessment. Glutamate oxaloacetate transaminase 1 (GOT1) is essential for cell proliferation and a...

Full description

Bibliographic Details
Main Authors: Zhiheng Cheng, Yifeng Dai, Tiansheng Zeng, Yan Liu, Longzhen Cui, Tingting Qian, Chaozeng Si, Wenhui Huang, Ying Pang, Xu Ye, Jinlong Shi, Lin Fu
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-03-01
Series:Frontiers in Oncology
Subjects:
acute myeloid leukemia
glutamate oxaloacetate transaminase 1
chemotherapy
allogeneic hematopoietic stem cell transplantation
prognosis
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.00379/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.00379/full

Similar Items